Tumor-derived exosomes can contribute to breast cancer development by converting adipose tissue-MSCs into tumor-associated myofibroblasts, and exosome treatment can increase the expression of tumor-stimulating molecules (SDF-1, VEGF, CCL5 and TGFβ) [73]. This evidence concerns the gene VEGFA and neoplasm.